Episurf Medical AB’s 2025 annual report is now available
Episurf Medical’s annual report for 2025 is available as of today at the company’s website, www.episurf.com.
Episurf Medical has of environmental and cost reasons chosen not to print the annual report. A printed version of the annual report will be distributed to shareholders and others who made such request. The annual report can also be ordered from Episurf Medical on the following address: Episurf Medical AB, Karlavägen 60, 114 49 Stockholm, Sweden or by email: ir@episurf.com.
For further information, please contact:
Jens Andersson, CEO, Episurf Medical
Email: jens.andersson@episurf.com
Sanja Batljan, CFO, Episurf Medical
Email: sanja.batljan@episurf.com
About Episurf Medical AB
Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The Company aims to deliver expansive value creation through Nordic yielding properties, with a focus on commercial and industrial buildings. The Company also has a medical technology business which is based on the individualised implant Episealer® and related surgical instruments, which are used for treating cartilage damage in joints. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, visit the company’s website: www.episurf.com
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] =>
[HtmlContact:protected] =>
[HtmlTitle:protected] => <h1 style="line-height:120%">Episurf Medical AB’s 2025 annual report is now available</h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical’s annual report for 2025 is available as of today at the company’s website, www.episurf.com.
Episurf Medical has of environmental and cost reasons chosen not to print the annual report. A printed version of the annual report will be distributed to shareholders and others who made such request. The annual report can also be ordered from Episurf Medical on the following address: Episurf Medical AB, Karlavägen 60, 114 49 Stockholm, Sweden or by email: ir@episurf.com.
For further information, please contact:
Jens Andersson, CEO, Episurf Medical
Email: jens.andersson@episurf.com
Sanja Batljan, CFO, Episurf Medical
Email: sanja.batljan@episurf.com
About Episurf Medical AB
Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The Company aims to deliver expansive value creation through Nordic yielding properties, with a focus on commercial and industrial buildings. The Company also has a medical technology business which is based on the individualised implant Episealer® and related surgical instruments, which are used for treating cartilage damage in joints. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, visit the company’s website: www.episurf.com
[HtmlBody:protected] => <p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{98}" paraid="324039397" style="margin-top:12px"><span>Episurf Medical’s annual report for 2025 is available as of today at the company’s website, <a href="https://www.episurf.com/" target="_blank">www.episurf.com</a>. </span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{120}" paraid="273971593"><span>Episurf Medical has of environmental and cost reasons chosen not to print the annual report. A printed version of the annual report will be distributed to shareholders and others who made such request. The annual report can also be ordered from Episurf Medical on the following address: Episurf Medical AB, Karlavägen 60, 114 49 Stockholm, Sweden or by email: <a href="mailto:ir@episurf.com" target="_blank">ir@episurf.com</a>. </span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{138}" paraid="675270984"><span>For further information, please contact: </span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{144}" paraid="860649599"><span>Jens Andersson, CEO, Episurf Medical </span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{150}" paraid="1900963287"><span>Email: <a href="mailto:jens.andersson@episurf.com" target="_blank">jens.andersson@episurf.com</a></span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{180}" paraid="1735319179"><span>Sanja Batljan, CFO, Episurf Medical <br>
Email: <a href="mailto:sanja.batljan@episurf.com" target="_blank">sanja.batljan@episurf.com</a></span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{204}" paraid="473314918"><span>About Episurf Medical AB </span></p>
<p paraeid="{853af625-5480-4e53-969f-ff24753eda02}{210}" paraid="1725013939"><span>Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The Company aims to deliver expansive value creation through Nordic yielding properties, with a focus on commercial and industrial buildings. The Company also has a medical technology business which is based on the individualised implant Episealer® and related surgical instruments, which are used for treating cartilage damage in joints. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, visit the company’s website: www.episurf.com </span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => EU Transparency SE
[Name:protected] => SeFsaCategoryCode
[Value:protected] => R1
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => OMX Filing (OMX CNS)
[Name:protected] => OMX CategoryCode
[Value:protected] => 270
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] =>
[Contact:protected] =>
[Header:protected] =>
[Keywords:protected] => Array
(
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/4324229/3996141.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Annual Report 2025
[Description:protected] => Annual Report 2025
[CreateDate:protected] => 2026-03-20T16:30:03.81Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
[1] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] =>
[MediaType:protected] => Esef
[Url:protected] => https://mb.cision.com/Main/14691/4324229/3996153.xbri
[FileName:protected] => wkr0008.xbri
[Title:protected] => 549300GORBCSMHZB2J75-2025-12-31-1-sv(ESEF).xbri
[Description:protected] => 549300GORBCSMHZB2J75-2025-12-31-1-sv(ESEF).xbri
[CreateDate:protected] => 2026-03-20T16:30:03.823Z
[Keywords:protected] => Array
(
)
[Extension:protected] => xbri
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 5328272
[EncryptedId:protected] => F4E51E82408EB2CE
[IsRegulatory:protected] => 1
[PublishDate:protected] => 2026-03-20T16:30:00Z
[LastChangeDate:protected] => 2026-03-20T16:30:03.793Z
[Title:protected] => Episurf Medical AB’s 2025 annual report is now available
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => RDV
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-ab-s-2025-annual-report-is-now-available,c4324229
[LanguageVersions:protected] => Array
(
[0] => CisionBlockPro\Cision\LanguageVersion Object
(
[Code:protected] => sv
[ReleaseId:protected] => 5328278
)
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)